Concepedia

Sujatro Chakladar

SC

Statistics

Publications

9

Citations

924

H-Index

9

Active since

2015

Affiliations

Eli Lilly (United States)(Current)

University of North Carolina at Chapel Hill

University of Minnesota

University of Illinois Chicago

University of Bristol

Sujatro Chakladar is an author at Eli Lilly (United States) specializing in critical care management, clinical trials, and critical care medicine.

ORCID

Top concepts

Publications per year

2015–2024

9

Publications

9

Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity

Atul Malhotra, Ronald R. Grunstein, Ingo Fietze et al. · New England Journal of Medicine · 2024 · 511 citations · Full text

Reducing the Blood Pressure–Related Burden of Cardiovascular Disease: Impact of Achievable Improvements in Blood Pressure Prevention and Control

Shakia T. Hardy, Laura R. Loehr, Kenneth R. Butler et al. · Journal of the American Heart Association · 2015 · 211 citations · Full text

Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 trial

Atul Malhotra, Josef Bednařík, Sujatro Chakladar et al. · Contemporary Clinical Trials · 2024 · 61 citations · Full text

Heterogeneity in Blood Pressure Transitions Over the Life Course

Shakia T. Hardy, Katelyn M. Holliday, Sujatro Chakladar et al. · JAMA Cardiology · 2017 · 39 citations · Full text

Efficacy and safety of baricitinib in patients with COVID-19 infection: Results from the randomised, double-blind, placebo-controlled, parallel-group COV-BARRIER phase 3 trial

Vincent C. Marconi, Athimalaipet V Ramanan, Stephanie de Bono et al. · 2021 · 36 citations · Full text

, , +19

1–5 of 9